Xiao Diaby Slider

POP faculty publish findings on cancer and quality of life

The study, partially funded by a UF College of Pharmacy PROSPER award, was published in Pharmacoeconomics Open.

Dr. Jenny Wei analyzes data on a TV screen

Dr. Yu-Jung “Jenny” Wei featured in TODAY Show video for Int’l Women’s Day

Wei, Ph.D., an assistant professor of pharmaceutical outcomes and policy, shares the advice she’d give to her younger self in this video produced for the Today Show online.

Hepatology journal cover

‘Hepatology’ journal selects Dr. Haesuk Park’s article for editorial highlight

The article titled, “Chronic hepatitis C virus (HCV) increases the risk of chronic kidney disease (CKD) while effective HCV treatment decreases the incidence of CKD,” was selected for an editorial highlight by the journal which has an impact factor of 13.25.

POP Research Showcase 2018

Li and Dawwas earn top honors at the 31st Annual Research Showcase

The pair were among eight students who competed in the oral competition at the UF College of Pharmacy’s annual event.

Dr. Karam Diaby, UF Pharmacy Faculty, College of Pharmacy

Dr. Diaby’s MTM study published in the Journal of Managed Care and Specialty Pharmacy

Diaby’s team used a decision analytic model to simulate and compare the cost and effectiveness associated with treatment strategies.

Navarro Press Release

Risk-sharing contracts could reduce U.S. drug prices

UF College of Pharmacy researchers studied performance-based risk-sharing agreements in Europe and the United States to identify opportunities to reduce drug costs for patients.

Prev Next

Welcome to the Department of Pharmaceutical Outcomes and Policy

Thank you for your interest in our program. We are proud of our outstanding faculty, graduate students, fellows and staff who possess a passion and commitment to both teaching and research.

The Department of Pharmaceutical Outcomes and Policy includes a broad range of programs and resources. Faculty is actively engaged in the entry-level PharmD program and its own graduate program, including about 25 PhD students, a small number of residential and more than 150 online MS students. alt text here

The Department’s focus in research and graduate training is centered on the evaluation of drugs and related medical technology. This focus includes classic pharmacoepidemiologic and pharmacoeconomic work in areas such as drug safety and comparative effectiveness, as well as patient safety and program evaluation as related to medication use. We have excellent facilities for quantitative research including a data center with a state-of the art 32TB privacy-approved research server and a variety of billing record and clinical research databases.

UF Health, the largest fully integrated academic health center in the Southeast with all six health colleges on campus, allows broad interdisciplinary collaboration as well as access to a fully integrated electronic health record system. Our graduate program admits students each fall semester and we frequently offer fellowship and internship opportunities.

Almut G. Winterstein, Ph.D.
Department Chair

POP Highlights and Fact Sheet

65 plus published manuscripts in 2016, 30 Ph.D. students, 10 faculty in Ph.D. program, 260 million records of health care data

Meet Current POP Students


Seminar announcement.

POP Seminar Announcement: Omotola Olasupo and Chintal Shah

The UF College of Pharmacy Department of Pharmaceutical Outcomes and Policy welcomes Omotola Olasupo and Chintal Shah as our March 20th, 2018 POP Seminar Presenters. Omotola Olasupo is a third-year student in the Dept […]


POP Seminar Announcement: Phuong Pham and Mahek Garg

The UF College of Pharmacy Department of Pharmaceutical Outcomes and Policy welcomes Phuong Pham and Mahek Garg as our February 13th, 2018 POP Seminar Presenters. Phuong is a second year PhD student in […]